Taiwan Green Cross has long focused on the manufacture of the thrombolytic agent Urokinase, with more than 50 years of experience promoting the product to hospitals and clinics in Taiwan. In recent years, the company has also worked to bring Urokinase to international markets.
The company continues to hold academic seminars through hospital and clinic channels, deepening understanding of Urokinase across clinical specialties in Taiwan and sharing the latest clinical applications and case reports to support healthcare professionals' knowledge of the product.
Seminars held in June and July
In June and July this year, Taiwan Green Cross held product seminars and clinical case-sharing sessions at the following institutions:
- Northern Taiwan: Pharmacy Department, Taoyuan General Hospital, Ministry of Health and Welfare
- Southern Taiwan: Cardiac Catheterisation Laboratory, Pingtung Christian Hospital
- Southern Taiwan: Department of Radiology, Pingtung Veterans General Hospital
Continuing clinical academic exchange
Taiwan Green Cross will continue to work with medical centres, hospitals and clinics across Taiwan, providing clinical knowledge and contributing to public health.
About Taiwan Green Cross
Taiwan Green Cross focuses on prescription pharmaceuticals, medical devices and healthcare. We are committed to introducing and developing innovative medical technologies and products, offering clinical professionals and patients more complete treatment and care options, while actively expanding into international markets to advance the globalisation of Taiwan's healthcare industry.